LWANC
EBS icon

Laurel Wealth Advisors (North Carolina)’s Emergent Biosolutions EBS Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$2K – 648
2022
Q1 		$2K Hold
50
– – ﹤0.01% 577
2021
Q4 		$2K Hold
50
– – ﹤0.01% 579
2021
Q3 		$3K Hold
50
– – ﹤0.01% 542
2021
Q2 		$3K Hold
50
– – ﹤0.01% 605
2021
Q1 		$5K Hold
50
– – ﹤0.01% 495
2020
Q4 		$4K Buy
+50
New +$4.59K ﹤0.01% 497

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s EBS Position: Q2 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 50 shares — an estimated $2K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in EBS in Q4 2020 and held it in 6 quarters. The position peaked at $5K in Q1 2021. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 50 Emergent Biosolutions shares in Q2 2022, an estimated $2K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Emergent Biosolutions in Q4 2020 and held it in 6 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Emergent Biosolutions position peaked at $5K in Q1 2021.
  • 232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2022, filed 12 Aug 2022.